Calories or Time Restriction to Alter Biomarkers of Aging and Diabetes
OMIT
The Effects of Caloric Restriction Plus Time Restriction on Glycemia, Circadian Rhythms and Cardiometabolic Health
1 other identifier
interventional
114
1 country
1
Brief Summary
Type 2 diabetes and cardiovascular disease are an increasing problem in Australia and around the world, and are partly linked to increased rates of obesity, together with sedentary lifestyles. This study will compare caloric restriction (CR) diets that restrict the amount of food that is eaten with CR diets that also restrict the time that the food is eaten, to either early or late in the day, on risk factors for type 2 diabetes and cardiovascular diseases over 2 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2023
CompletedFirst Posted
Study publicly available on registry
March 15, 2023
CompletedStudy Start
First participant enrolled
March 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2025
CompletedMay 9, 2025
May 1, 2025
1.7 years
March 1, 2023
May 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glucose area under curve (AUC) after 3 meals
Change in glucose AUC after 3 meals
8 weeks
Secondary Outcomes (4)
Insulin area under the curve (AUC)
8 weeks
Fasting insulin
8 weeks
Fasting glucose
8 weeks
Change in glycated hemoglobin (HbA1c)
8 weeks
Other Outcomes (20)
Postprandial glucose and insulin AUC of each meal
8 weeks
Non-esterified fatty acids (fasting, postprandial AUC)
8 weeks
Triglycerides (fasting, postprandial AUC)
8 weeks
- +17 more other outcomes
Study Arms (3)
early calorie restriction (eCR)
EXPERIMENTALIndividuals will be provided with menus prescribed at 70% of calculated energy requirements and instructed to eat within 8 h/day (e.g. 8:00 - 16:00) every day for 8 weeks, except 1 evening meal per week off the program (i.e. Saturday nights) to assist with overall adherence.
delayed calorie restriction (dCR)
EXPERIMENTALIndividuals will be provided with menus prescribed at 70% of calculated energy requirements and instructed to eat within 8 h/day (e.g 12:00 - 20:00) every day for 8 weeks, except 1 evening meal per week off the program (i.e. Saturday nights) to assist with overall adherence.
Calorie restriction (CR)
ACTIVE COMPARATORIndividuals will be provided with menus prescribed at 70% of calculated energy requirements every day for 8 weeks. The menus will encourage breakfast and after-dinner consumption of the snack to eat over at least a 12 hour time frame per day (e.g. 8:00 - 20:00), except 1 evening meal per week off the program (i.e. Saturday nights) to assist with overall adherence.
Interventions
Eligibility Criteria
You may qualify if:
- Overweight or obesity (BMI 25.1 - 44.9 kg/m2)
- Elevated waist circumference (race specific),
- Elevated fasting blood glucose (\>5.6 mmol/L).
You may not qualify if:
- A personal history/diagnosis (self-reported) of:
- diabetes (type 1 or 2)
- major psychiatric disorders (schizophrenia, major depressive disorder, bipolar disorder, eating disorders)
- gastrointestinal disorders/disease (including malabsorption)
- haematological disorders (i.e. thalassemia, iron-deficiency anaemia)
- insomnia
- obstructive sleep apnea
- night eating syndrome
- diagnosis or treatment of cancer in the past 3 years (excluding non-melanoma skin cancer)
- significant liver or kidney diseases that require ongoing medical care
- previous or planned gastro-intestinal surgery (including bariatric surgery)
- Congestive heart failure (NYHA stage 2 or above)
- Previous myocardial infarction or significant cardiac event ≤ 6 months prior to screening
- Previous cerebrovascular event ≤ 12 months prior to screening
- Any autoimmune disease (i.e. rheumatoid arthritis)
- +24 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Adelaidelead
- University of Sydneycollaborator
- Salk Institute for Biological Studiescollaborator
Study Sites (1)
South Australian Health and Medical Research Institute / The University of Adelaide
Adelaide, South Australia, 5000, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leonie Heilbronn, PhD.
The University of Adelaide
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Group Leader, Obesity and Metabolism
Study Record Dates
First Submitted
March 1, 2023
First Posted
March 15, 2023
Study Start
March 15, 2023
Primary Completion
December 10, 2024
Study Completion
April 17, 2025
Last Updated
May 9, 2025
Record last verified: 2025-05